Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of brepocitinib for dermatomyositis, and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• Brepocitinib (brepocitinib)

Snippet

Sponsor: Priovant Therapeutics, Inc. | Conditions: Dermatomyositis | Phase 3 | Status: ACTIVE_NOT_RECRUITING